Etrolizumab for induction of remission in ulcerative colitis
Greg Rosenfeld(British Columbia Centre on Substance Use), Brian Bressler(University of British Columbia), Claire E Parker(Robarts Clinical Trials), John K MacDonald(Align Technology (United States))
Cited by 10
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478